Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor

Journal of Biological Chemistry

Volumn 287, Issue 13, 2012, Pages 9753-9764

  Kuo, Po Lin ^a,b   Huang, Ming Shyan ^b   Cheng, Da En ^c   Hung, Jen Yu ^b,c   Yang, Chih Jen ^b,c   Chou, Shah Hwa ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMOR AGENTS; CANCER CELLS; CANCER DEVELOPMENT; CANCER PROGRESSION; CONDITIONED MEDIUM; CONVERTING ENZYME; DENDRITIC CELLS; ECTODOMAIN SHEDDING; GALECTIN-1; GROWTH FACTOR; HEPARIN BINDING; HUMAN LUNG; INDUCTIVE EFFECTS; LEWIS LUNG CARCINOMATA; LUNG CANCER; METALLOPROTEINASE-9; MICROENVIRONMENTS; PROTEIN KINASE C; SURVIVAL RATE; THERAPEUTIC POTENTIALS; UP-REGULATION;

BIOLOGICAL ORGANS; CELLS; ENZYME ACTIVITY; MAMMALS; PATIENT TREATMENT; PEPTIDES; POLYSACCHARIDES; TUMORS;

DISEASES;

ADAM PROTEIN; ADAM9 PROTEIN; GALECTIN 1; GLYCOPROTEIN P 15095; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PROTEIN KINASE C DELTA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LEWIS CARCINOMA; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAM PROTEINS; ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD11C; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DENDRITIC CELLS; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEIN KINASE C-DELTA; UP-REGULATION;

MUS;

EID: 84858977200     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.321190     Document Type: Article

References (34)

1. Andrews, J., Yeh, P., Pao, W., and Horn, L. (2011) Molecular predictors of response to chemotherapy in non-small cell lung cancer. Cancer J. 17, 104-113
2. Sautès-Fridman, C., Cherfils-Vicini, J., Damotte, D., Fisson, S., Fridman, W. H., Cremer, I., and Dieu-Nosjean, M. C. (2011) Tumor microenvironment is multifaceted. Cancer Metastasis Rev. 30, 13-25
3. Bremnes, R. M., Al-Shibli, K., Donnem, T., Sirera, R., Al-Saad, S., Andersen, S., Stenvold, H., Camps, C., and Busund, L. T. (2011) The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis. Emphasis on non-small cell lung cancer. J. Thorac. Oncol. 6, 824-833
4. Eikawa, S., Ohue, Y., Kitaoka, K., Aji, T., Uenaka, A., Oka, M., and Nakayama, E. (2010) Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J. Immunol. 185, 6734-6740
5. Domínguez-Soto, A., Sierra-Filardi, E., Puig-Kröger, A., Pérez-Maceda, B., Gómez-Aguado, F., Corcuera, M. T., Sánchez-Mateos, P., and Corbí, A. L. (2011) Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10. J. Immunol. 186, 2192-2200
6. Mantovani, A., Savino, B., Locati, M., Zammataro, L., Allavena, P., and Bonecchi, R. (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 21, 27-39
7. Sunnarborg, S. W., Hinkle, C. L., Stevenson, M., Russell, W. E., Raska, C. S., Peschon, J. J., Castner, B. J., Gerhart, M. J., Paxton, R. J., Black, R. A., and Lee, D. C. (2002) Tumor necrosis factor α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277, 12838-12845 (Pubitemid 34952648)
8. Miyamoto, S., Yagi, H., Yotsumoto, F., Kawarabayashi, T., and Mekada, E. (2008) Heparin-binding epidermal growth factor-like growth factor as a new target molecule for cancer therapy. Adv. Exp. Med. Biol. 622, 281-295
9. Sagmeister, S., Drucker, C., Losert, A., Grusch, M., Daryabeigi, A., Parzefall, W., Rohr-Udilova, N., Bichler, C., Smedsrød, B., Kandioler, D., Grünberger, T., Wrba, F., Schulte-Hermann, R., and Grasl-Kraupp, B. (2008) HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis. J. Hepatol. 49, 955-964
10. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S., and Mekada, E. (1998) A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17, 7260-7272 (Pubitemid 29002695)
11. Yotsumoto, F., Yagi, H., Suzuki, S. O., Oki, E., Tsujioka, H., Hachisuga, T., Sonoda, K., Kawarabayashi, T., Mekada, E., and Miyamoto, S. (2008) Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem. Biophys. Res. Commun. 365, 555-561 (Pubitemid 350181687)
12. Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G., Nanba, D., Higashiyama, S., Hori, M., Klagsbrun, M., and Mekada, E. (2003) Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. U.S.A. 100, 3221-3226 (Pubitemid 36356564)
13. Nakao, S., Noda, K., Zandi, S., Sun, D., Taher, M., Schering, A., Xie, F., Mashima, Y., and Hafezi-Moghadam, A. (2011) VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis. Am. J. Pathol. 178, 1913-1921
14. Solinas, G., Schiarea, S., Liguori, M., Fabbri, M., Pesce, S., Zammataro, L., Pasqualini, F., Nebuloni, M., Chiabrando, C., Mantovani, A., and Allavena, P. (2010) Tumor-conditioned macrophages secrete migration-stimulating factor. A new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 185, 642-652
15. Bian, Y., Terse, A., Du, J., Hall, B., Molinolo, A., Zhang, P., Chen, W., Flanders, K. C., Gutkind, J. S., Wakefield, L. M., and Kulkarni, A. B. (2009) Progressive tumor formation in mice with conditional deletion of TGF-β signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. Cancer Res. 69, 5918-5926
16. Kuo, P. L., Hung, J. Y., Huang, S. K., Chou, S. H., Cheng, D. E., Jong, Y. J., Hung, C. H., Yang, C. J., Tsai, Y. M., Hsu, Y. L., and Huang, M. S. (2011) Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway. J. Immunol. 186, 1521-1530
17. Zhao Y., He, D., Saatian, B., Watkins, T., Spannhake, E. W., Pyne, N. J., and Natarajan, V. (2006) Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cδ, Lyn kinase, and matrix metalloproteinases. J. Biol. Chem. 281, 19501-19511 (Pubitemid 44035454)
18. Kveiborg, M., Instrell, R., Rowlands, C., Howell, M., and Parker, P. J. (2011) PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding EGF through separate pathways. PLoS ONE 6, e17168
19. Box, C., Rogers, S. J., Mendiola, M., and Eccles, S. A. (2010) Tumour-microenvironmental interactions. Paths to progression and targets for treatment. Semin. Cancer Biol. 20, 128-138
20. Kwong, C., Gilman-Sachs, A., and Beaman, K. (2011) Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes. J. Immunol. 186, 1781-1789
21. Cao, Y., Zhang, L., Kamimura, Y., Ritprajak, P., Hashiguchi, M., Hirose, S., and Azuma, M. (2011) B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin. Cancer Res. 71, 1235-1243
22. Hu, C. E., Gan, J., Zhang, R. D., Cheng, Y. R., and Huang, G. J. (2011) J. Gastroenterol. 46, 156-164
23. Koh, H. S., Lee, C., Lee, K. S., Park, E. J., Seong, R. H., Hong, S., and Jeon, S. H. (2009) Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells. Mol. Cells 28, 553-558
24. Gandhi, M. K., Moll, G., Smith, C., Dua, U., Lambley, E., Ramuz, O., Gill, D., Marlton, P., Seymour, J. F., and Khanna, R. (2007) Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma. Blood 110, 1326-1329 (Pubitemid 47281432)
25. Kiss, J., Kunstár, A., Fajka-Boja, R., Dudics, V., Tóvári, J., Légrádi, A., Monostori, E., and Uher, F. (2007) A novel anti-inflammatory function of human galectin-1. Inhibition of hematopoietic progenitor cell mobilization. Exp. Hematol. 35, 305-313 (Pubitemid 46135807)
26. Yasumoto, K., Yamada, T., Kawashima, A., Wang, W., Li, Q., Donev, I. S., Tacheuchi, S., Mouri, H., Yamashita, K., Ohtsubo, K., and Yano, S. (2011) The EGFR ligands amphiregulin and heparin-binding EGF-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Clin. Cancer Res. 17, 3619-3630
27. Tanaka, Y., Miyamoto, S., Suzuki, S. O., Oki, E., Yagi, H., Sonoda, K., Yamazaki, A., Mizushima, H., Maehara, Y., Mekada, E., and Nakano, H. (2005) Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin. Cancer Res. 11, 4783-4792 (Pubitemid 41557199)
28. Yin, Y., Grabowska, A. M., Clarke, P. A., Whelband, E., Robinson, K., Argent, R. H., Tobias, A., Kumari, R., Atherton, J. C., and Watson, S. A. (2010) Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer. Links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut 59, 1037-1045
29. Yotsumoto F., Oki, E., Tokunaga, E., Maehara, Y., Kuroki, M., and Miyamoto, S. (2010) HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer. Int. J. Cancer 127, 2707-2717
30. Zhang, Z., Stiegler, A. L., Boggon, T. J., Kobayashi, S., and Halmos, B. (2010) EGFR-mutated lung cancer. A paradigm of molecular oncology. Oncotarget 1, 497-514
31. Pines, G., Köstler, W. J., Yarden, Y. (2010) Oncogenic mutant forms of EGFR. Lessons in signal transduction and targets for cancer therapy. FEBS Lett. 584, 2699-2706
32. Nakagawa, M., Nabeshima, K., Asano, S., Hamasaki, M., Uesugi, N., Tani, H., Yamashita, Y., and Iwasaki, H. (2009) Up-regulated expression of ADAM17 in gastrointestinal stromal tumors. Coexpression with EGFR and EGFR ligands. Cancer Sci. 100, 654-662
33. Uchiyama, K., Saito, M., Sasaki, M., Obara, Y., Higashiyama, S., and Nakahata, N. (2009) Thromboxane A2 receptor-mediated epidermal growth factor receptor transactivation. Involvement of PKCδ and PKCε in the shedding of epidermal growth factor receptor ligands. Eur. J. Pharm. Sci. 38, 504-511
34. Maretzky, T., Evers, A., Zhou, W., Swendeman, S. L., Wong, P. M., Rafii, S., Reiss, K., and Blobel, C. P. (2011) Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. Nat. Commun. 2, 229